Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dermot S O'Callaghan

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Chest|February 2, 2010
Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosisBruno Degano, Olivier Sitbon, Laurent Savale, et al.
Presse Medicale (Paris, France : 1983)|November 9, 2015
[Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin]Athénaïs Boucly, Caroline O'Connell, Laurent Savale, et al.
Expert Opinion on Pharmacotherapy|April 21, 2011
Endothelin receptor antagonists for the treatment of pulmonary arterial hypertensionDermot S O'Callaghan, Laurent Savale, Azzedine Yaïci, et al.
Respiratory Medicine|May 12, 2010
Pulmonary veno-occlusive disease: recent progress and current challengesDavid Montani, Dermot S O'Callaghan, Laurent Savale, et al.
The European Respiratory Journal|June 2, 2012
Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertensionLaurent Savale, Romain Magnier, Jérôme Le Pavec, et al.
Respiration; International Review of Thoracic Diseases|August 22, 2012
Renal replacement therapy in patients with severe precapillary pulmonary hypertension with acute right heart failureBenjamin Sztrymf, Dominique Prat, Frédéric M Jacobs, et al.
The European Respiratory Journal|November 7, 2015
Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancerDermot S O'Callaghan, Elton Rexhepaj, Kathy Gately, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutationBarbara Girerd, David Montani, Florence Coulet, et al.
Chest|April 13, 2013
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthmaGilles Garcia, Antoine Magnan, Raphaël Chiron, et al.
The New England Journal of Medicine|July 8, 2011
A hemodynamic study of pulmonary hypertension in sickle cell diseaseFlorence Parent, Dora Bachir, Jocelyn Inamo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Chest|February 2, 2010
Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosisBruno Degano, Olivier Sitbon, Laurent Savale, et al.
Presse Medicale (Paris, France : 1983)|November 9, 2015
[Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin]Athénaïs Boucly, Caroline O'Connell, Laurent Savale, et al.
Expert Opinion on Pharmacotherapy|April 21, 2011
Endothelin receptor antagonists for the treatment of pulmonary arterial hypertensionDermot S O'Callaghan, Laurent Savale, Azzedine Yaïci, et al.
Respiratory Medicine|May 12, 2010
Pulmonary veno-occlusive disease: recent progress and current challengesDavid Montani, Dermot S O'Callaghan, Laurent Savale, et al.
The European Respiratory Journal|June 2, 2012
Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertensionLaurent Savale, Romain Magnier, Jérôme Le Pavec, et al.
Respiration; International Review of Thoracic Diseases|August 22, 2012
Renal replacement therapy in patients with severe precapillary pulmonary hypertension with acute right heart failureBenjamin Sztrymf, Dominique Prat, Frédéric M Jacobs, et al.
The European Respiratory Journal|November 7, 2015
Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancerDermot S O'Callaghan, Elton Rexhepaj, Kathy Gately, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutationBarbara Girerd, David Montani, Florence Coulet, et al.
Chest|April 13, 2013
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthmaGilles Garcia, Antoine Magnan, Raphaël Chiron, et al.
The New England Journal of Medicine|July 8, 2011
A hemodynamic study of pulmonary hypertension in sickle cell diseaseFlorence Parent, Dora Bachir, Jocelyn Inamo, et al.
Pageof 3